SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001062993-23-019065
Filing Date
2023-10-05
Accepted
2023-10-05 16:32:34
Documents
2
Period of Report
2023-10-03

Document Format Files

Seq Description Document Type Size
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.html 3  
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.xml 3 1552
2 POA exhibit24-1.txt EX-24.1 2579
  Complete submission text file 0001062993-23-019065.txt   5716
Mailing Address C/O IDM PHARMA, INC. 9 PARKER, SUITE 100 IRVINE CA 92618
Business Address
SHERMAN JEFFREY W (Reporting) CIK: 0001230482 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36510 | Film No.: 231311759

Mailing Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004
Business Address THREE BALA PLAZA EAST. SUITE 506 BALA CYNWYD PA 19004 844-511-9056
Larimar Therapeutics, Inc. (Issuer) CIK: 0001374690 (see all company filings)

IRS No.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations